Olacaftor Uses, Dosage, Side Effects and more
Olacaftor is under investigation in clinical trial NCT02951182 (A Study Evaluating the Safety and Efficacy of VX-440 Combination Therapy in Subjects With Cystic Fibrosis).
| Trade Name | Olacaftor |
| Generic | Olacaftor |
| Olacaftor Other Names | Olacaftor |
| Type | |
| Formula | C29H34FN3O4S |
| Weight | Average: 539.67 Monoisotopic: 539.225405924 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
